Stockholm, Sweden

Oncopeptides Ab


USPTO Granted Patents = 10



Trademarks = 7

Forward Citations = 17

Loading Chart...
Loading Chart...

10 inventors (with patents filed for the assignee):

goldMedal Jack Spira (7 out of 10 patents)

silverMedal Fredrik Lehmann (7 out of 12 patents)

bronzeMedal Niklas Håkan Wahlström (1 out of 1 patent)

4 Johan Anders Wennerberg (1 out of 1 patent)

5 Rolf Larsson (1 out of 10 patents)

6 Rolf Lewensohn (1 out of 1 patent)

7 Joakim Gullbo (1 out of 1 patent)

8 Hans Ehrsson (1 out of 1 patent)

9 Kristina Luthman (1 out of 1 patent)

10 Jakob Lindberg (1 out of 1 patent)

11 Rolf Larsson (0 patent)

12 Hans Ehrsson (0 patent)

13 Niklas Håkan WAHLSTRÖM (0 patent)


10 patents:

Oncopeptides is a pharmaceutical company focused on developing and commercializing novel therapies to treat rare and aggressive cancers. Their lead product candidate, melflufen, is being studied for the treatment of multiple myeloma and other hematologic cancers. The company is dedicated to improving the lives of patients with few treatment options through innovative drug development strategies.
This text is generated by artificial intelligence and may not be accurate.

logo

Company Badge

USPTO Data Jan 1 1976 - Dec 23 2025

...
10 Patents

#82 in Stockholm

#572 in Sweden

#54,287 in the World

...
Stockholm, Sweden
Forward Citations = 17

10 inventors:

Please report any incorrect information to support@idiyas.com
Loading…